in this issue
Regions :: Western Europe
Pfizer confirms interest in AstraZeneca, will hold investor call today
9:37 AM MDT | April 28, 2014 | Natasha Alperowicz
Pfizer said today that it approached AstraZeneca on Saturday seeking to renew discussions, which could lead to the merger of the two companies. The news follows an initial approach by Pfizer in January, which was rejected by AstraZeneca. Pfizer says that such a transaction would bring together highly complementary, innovative, and established pharmaceutical businesses, enhancing the combined company’s ability to meet patients’ needs. Pfizer says that, in January, it submitted a preliminary, nonbinding indication of interest to the board of...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee